Chengcheng Li

发表

Circulating cell-free DNA for cancer early detection

S. Cai, Zhijie Wang, Q. Gao, 2022, Innovation (Cambridge (Mass.)).

Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO+IPI: a systematic review and meta-analysis

P. Xing, Junling Li, Yan Wang, 2019, Journal of Immunotherapy for Cancer.

Plasma cfDNA methylation markers for the detection and prognosis of ovarian cancer

S. Cai, Yu Zhang, G. Yuan, 2022, EBioMedicine.

Co-occurring genomic alterations and immunotherapy efficacy in NSCLC

Y. Hu, Jin-liang Wang, Guoqiang Wang, 2022, npj Precision Oncology.

Identification and validation of tissue or ctDNA PTPRD phosphatase domain deleterious mutations as prognostic and predictive biomarkers for immune checkpoint inhibitors in non-squamous NSCLC

H. Bai, S. Cai, J. Duan, 2021, BMC Medicine.

EPHA mutation as a predictor of immunotherapeutic efficacy in lung adenocarcinoma

H. Bai, Guoqiang Wang, S. Cai, 2020, Journal for ImmunoTherapy of Cancer.

Identification of Deleterious NOTCH Mutation as Novel Predictor to Efficacious Immunotherapy in NSCLC

Z. Lou, Zhengyi Zhao, Guoqiang Wang, 2020, Clinical Cancer Research.

Discovery and validation of methylation signatures in circulating cell-free DNA for early detection of esophageal cancer: a case-control study

Haiyu Zhou, Guoqiang Wang, S. Cai, 2021, BMC Medicine.

TGFBR2 mutation predicts resistance to immune checkpoint inhibitors in patients with non-small cell lung cancer

Junling Li, Guoqiang Wang, S. Cai, 2021, Therapeutic advances in medical oncology.

Depth of Response was Associated with Progression-Free Survival in Patients with Advanced Non-small Cell Lung Cancer treated with EGFR-TKI

P. Xing, Yuankai Shi, Jun-ling Li, 2019, Journal of Cancer.

Discovery and validation of methylation signatures in blood-based circulating tumor cell-free DNA in early detection of colorectal carcinoma: a case–control study

Guanyu Yu, Z. Lou, Wei Zhang, 2021, Clinical Epigenetics.

Common DNA methylation changes in biliary tract cancers identify subtypes with different immune characteristics and clinical outcomes

Guoqiang Wang, S. Cai, Yan Zhu, 2022, BMC Medicine.

A pyroptosis-related gene signature for prognosis prediction in hepatocellular carcinoma

Yusheng Han, S. Cai, X. Mi, 2023, Frontiers in Oncology.

A prognostic and immunotherapeutic predictive model based on the cell-originated characterization of tumor microenvironment in lung adenocarcinoma

Pingzhang Chen, Yusheng Han, S. Cai, 2023, iScience.

Complement and coagulation cascades pathway-related signature as a predictor of immunotherapy in metastatic urothelial cancer

S. Cai, Wenxian Wang, Zheng Gong, 2023, Aging.

Start of an era: circulating cell-free DNA for early detection of cancers

Guoqiang Wang, S. Cai, Zhijie Wang, 2022, The Innovation.

Discovery and validation of methylation signatures in circulating cell-free DNA for early detection of esophageal cancer: a case-control study

Haiyu Zhou, Guoqiang Wang, S. Cai, 2021, BMC Medicine.